{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:58:29Z","timestamp":1793318309621,"version":"4.5.0"},"reference-count":63,"publisher":"American Society of Hematology","issue":"12","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,6,24]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Children with sickle cell anemia (SCA) frequently develop progressive neurocognitive impairment. We aimed to determine effects of hydroxyurea therapy on neurocognitive function in Ugandan children with SCA by comparing levels at enrollment to a planned 18-month interim assessment. Ugandan children (N = 264) aged 3 to 9 years attending SCA clinic were enrolled and treated in a 30-month, single-arm, open-label trial with escalation to maximum tolerated dose. Sibling controls (N = 110) without SCA underwent parallel neurocognitive testing to establish age-normalized z scores for comparison. At enrollment, mean participant age was 5.6 \u00b1 1.2 years, with comparable socioeconomic status and caregiver education vs. controls. Month 18 mean daily hydroxyurea dose was 25.4 mg\/kg. We found significantly improved participant z scores vs. baseline in all 3 neurocognitive domains tested: cognition: \u22120.54 \u00b1 1.10 vs. \u22120.07 \u00b1 1.16, P &amp;lt; .001; attention: \u22120.07 \u00b1 1.01 vs. 0.27 \u00b1 0.84, P &amp;lt; .001; and executive function: \u22120.06 \u00b1 0.62 vs. 0.08 \u00b1 0.72, P = .010. No month-18 measures differed from controls. Participants with SCA and cognitive impairment declined from 8.7% at enrollment to 4.0%, vs. 1.6% of controls; with decreased mean TCD velocity. Improved neurocognitive treatment z-scores were associated with higher baseline scores and socioeconomic status, hydroxyurea-associated lower TCD velocity, and hematological-induced effects, eg higher hemoglobin. Despite improvement, unadjusted neurocognitive scores remained negatively associated with age. Hydroxyurea therapy improved SCA neurocognitive function in sub-Saharan children, potentially aided by practice effects. Early treatment is needed for optimal impact. Our ongoing trial will assess impact from longer-term hydroxyurea therapy. This trial was registered at www.ClinicalTrials.gov as #NCT04750707.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2024015073","type":"journal-article","created":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T18:23:56Z","timestamp":1741976636000},"page":"3116-3127","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":7,"title":["Neurocognitive gains among Ugandan children with sickle cell anemia on hydroxyurea: 18-month interim trial results"],"prefix":"10.1182","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-5447-252X","authenticated-orcid":false,"given":"Shubaya K.","family":"Naggayi","sequence":"first","affiliation":[{"name":"1Department of Paediatrics and Child Health, Makerere University College of Health Sciences, Kampala, Uganda"},{"name":"2Global Health Uganda, Kampala, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5003-0414","authenticated-orcid":false,"given":"Dennis","family":"Kalibbala","sequence":"additional","affiliation":[{"name":"2Global Health Uganda, Kampala, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Mboizi","sequence":"additional","affiliation":[{"name":"2Global Health Uganda, Kampala, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Ssenkusu","sequence":"additional","affiliation":[{"name":"3Department of Epidemiology and Biostatistics, Makerere University College of Health Sciences, Kampala, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3801-0680","authenticated-orcid":false,"given":"Zhezhen","family":"Jin","sequence":"additional","affiliation":[{"name":"4Department of Biostatistics, Mailman School of Public Health, Columbia University Irving Medical Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Rosano","sequence":"additional","affiliation":[{"name":"5Department of Epidemiology, University of Pittsburgh, Pittsburgh, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1312-6804","authenticated-orcid":false,"given":"Deogratias","family":"Munube","sequence":"additional","affiliation":[{"name":"1Department of Paediatrics and Child Health, Makerere University College of Health Sciences, Kampala, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bill","family":"Wambaka","sequence":"additional","affiliation":[{"name":"2Global Health Uganda, Kampala, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Namazzi","sequence":"additional","affiliation":[{"name":"1Department of Paediatrics and Child Health, Makerere University College of Health Sciences, Kampala, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip","family":"Kasirye","sequence":"additional","affiliation":[{"name":"1Department of Paediatrics and Child Health, Makerere University College of Health Sciences, Kampala, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxencia","family":"Kabatabaazi","sequence":"additional","affiliation":[{"name":"2Global Health Uganda, Kampala, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Nambatya","sequence":"additional","affiliation":[{"name":"2Global Health Uganda, Kampala, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Murungi","sequence":"additional","affiliation":[{"name":"2Global Health Uganda, Kampala, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Nabaggala","sequence":"additional","affiliation":[{"name":"2Global Health Uganda, Kampala, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8133-3223","authenticated-orcid":false,"given":"Maria","family":"Nakafeero","sequence":"additional","affiliation":[{"name":"6Division of Hematology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6516-890X","authenticated-orcid":false,"given":"Ian R.","family":"Troidl","sequence":"additional","affiliation":[{"name":"5Department of Epidemiology, University of Pittsburgh, Pittsburgh, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Opoka","sequence":"additional","affiliation":[{"name":"7Aga Khan University Medical College, Nairobi, Kenya"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Idro","sequence":"additional","affiliation":[{"name":"1Department of Paediatrics and Child Health, Makerere University College of Health Sciences, Kampala, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Bangirana","sequence":"additional","affiliation":[{"name":"2Global Health Uganda, Kampala, Uganda"},{"name":"8Department of Psychiatry, Makerere University College of Health Sciences, Kampala, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9877-1561","authenticated-orcid":false,"given":"Nancy S.","family":"Green","sequence":"additional","affiliation":[{"name":"9Division of Hematology, Oncology, and Stem Cell Transplantion, Department of Pediatrics, Columbia University Irving Medical Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2025,6,24]]},"reference":[{"issue":"3","key":"2025062711213308400_bib1","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/MPH.0000000000002091","article-title":"Pediatric neurodevelopmental delays in children 0 to 5 years of age with sickle cell disease: a systematic literature review","volume":"43","author":"Knight","year":"2021","journal-title":"J Pediatr Hematol Oncol"},{"issue":"2","key":"2025062711213308400_bib2","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/bjh.17687","article-title":"Hydroxyurea treatment and neurocognitive functioning in sickle cell disease from school age to young adulthood","volume":"195","author":"Heitzer","year":"2021","journal-title":"Br J Haematol"},{"issue":"3","key":"2025062711213308400_bib3","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/bjh.18041","article-title":"Neurocognitive risk in sickle cell disease: utilizing neuropsychology services to manage cognitive symptoms and functional limitations","volume":"197","author":"Longoria","year":"2022","journal-title":"Br J Haematol"},{"issue":"6","key":"2025062711213308400_bib4","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1111\/bjh.16542","article-title":"Cognitive deficit in sickle cell disease: is hydroxyurea part of the story?","volume":"189","author":"Hyacinth","year":"2020","journal-title":"Br J Haematol"},{"issue":"6","key":"2025062711213308400_bib5","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1111\/bjh.16519","article-title":"Association between hydroxycarbamide exposure and neurocognitive function in adolescents with sickle cell disease","volume":"189","author":"Partanen","year":"2020","journal-title":"Br J Haematol"},{"issue":"7","key":"2025062711213308400_bib6","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1182\/blood-2015-09-618579","article-title":"Central nervous system complications and management in sickle cell disease","volume":"127","author":"DeBaun","year":"2016","journal-title":"Blood"},{"issue":"1","key":"2025062711213308400_bib7","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1186\/s12916-020-01864-8","article-title":"Silent cerebral infarcts in patients with sickle cell disease: a systematic review and meta-analysis","volume":"18","author":"Houwing","year":"2020","journal-title":"BMC Med"},{"key":"2025062711213308400_bib8","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ejpn.2022.01.010","article-title":"Effect of age, cerebral infarcts, vasculopathy and haemoglobin on cognitive function, in Tanzanian children with sickle cell anaemia","volume":"37","author":"Jacob","year":"2022","journal-title":"Eur J Paediatr Neurol"},{"issue":"2","key":"2025062711213308400_bib9","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/ajh.23604","article-title":"Parent education and biologic factors influence on cognition in sickle cell anemia","volume":"89","author":"King","year":"2014","journal-title":"Am J Hematol"},{"key":"2025062711213308400_bib10","doi-asserted-by":"crossref","first-page":"835823","DOI":"10.3389\/fneur.2022.835823","article-title":"Considerations for selecting cognitive endpoints and psychological patient-reported outcomes for clinical trials in pediatric patients with sickle cell disease","volume":"13","author":"Hood","year":"2022","journal-title":"Front Neurol"},{"issue":"2","key":"2025062711213308400_bib11","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/09297049.2011.640932","article-title":"Association between biological markers of sickle cell disease and cognitive functioning amongst Cameroonian children","volume":"19","author":"Ruffieux","year":"2013","journal-title":"Child Neuropsychol"},{"issue":"11","key":"2025062711213308400_bib12","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1002\/pbc.26126","article-title":"Cognitive functioning in children from Nigeria with sickle cell anemia","volume":"63","author":"Oluwole","year":"2016","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"2025062711213308400_bib13","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/bjh.18386","article-title":"A case-control and seven-year longitudinal neurocognitive study of adults with sickle cell disease in Ghana","volume":"199","author":"Ampomah","year":"2022","journal-title":"Br J Haematol"},{"issue":"1","key":"2025062711213308400_bib14","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1186\/s12887-019-1758-2","article-title":"Burden of neurological and neurocognitive impairment in pediatric sickle cell anemia in Uganda (BRAIN SAFE): a cross-sectional study","volume":"19","author":"Green","year":"2019","journal-title":"BMC Pediatr"},{"key":"2025062711213308400_bib15","doi-asserted-by":"crossref","first-page":"1372949","DOI":"10.3389\/fstro.2024.1372949","article-title":"Neurocognitive impairment in Ugandan children with sickle cell anemia compared to sibling controls: a cross-sectional study","volume":"3","author":"Bangirana","year":"2024","journal-title":"Front Stroke"},{"issue":"3","key":"2025062711213308400_bib16","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1067\/mpd.2001.116935","article-title":"Neuropsychologic performance in school-aged children with sickle cell disease: a report from the cooperative study of sickle cell disease","volume":"139","author":"Wang","year":"2001","journal-title":"J Pediatr"},{"issue":"3","key":"2025062711213308400_bib17","first-page":"532","article-title":"Neuroimaging and cognitive function in sickle cell disease: a systematic review","volume":"10","author":"Abdi","year":"2023","journal-title":"Children (Basel)"},{"issue":"8","key":"2025062711213308400_bib18","doi-asserted-by":"crossref","first-page":"e585","DOI":"10.1016\/S2352-3026(23)00118-7","article-title":"Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000-2021: a systematic analysis from the global burden of disease study 2021","volume":"10","author":"GBD 2021 Sickle Cell Disease Collaborators","year":"2023","journal-title":"Lancet Haematol"},{"key":"2025062711213308400_bib19","doi-asserted-by":"crossref","first-page":"101404","DOI":"10.1016\/j.conctc.2024.101404","article-title":"Hydroxyurea therapy for neurological and cognitive protection in pediatric sickle cell anemia in Uganda (BRAIN SAFE II): protocol for a single-arm open label trial","volume":"42","author":"Mboizi","year":"2024","journal-title":"Contemp Clin Trials Commun"},{"issue":"24","key":"2025062711213308400_bib20","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1182\/blood-2017-06-788935","article-title":"Novel use of hydroxyurea in an African region with malaria (NOHARM): a trial for children with sickle cell anemia","volume":"130","author":"Opoka","year":"2017","journal-title":"Blood"},{"issue":"26","key":"2025062711213308400_bib21","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1056\/NEJMoa2000146","article-title":"Hydroxyurea dose escalation for sickle cell anemia in sub-Saharan Africa","volume":"382","author":"John","year":"2020","journal-title":"N Engl J Med"},{"issue":"12","key":"2025062711213308400_bib22","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/ajh.24198","article-title":"Prevention of conversion to abnormal transcranial Doppler with hydroxyurea in sickle cell anemia: a phase III international randomized clinical trial","volume":"90","author":"Hankins","year":"2015","journal-title":"Am J Hematol"},{"issue":"2","key":"2025062711213308400_bib23","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/bjh.15162","article-title":"Transcranial Doppler velocity among Jamaican children with sickle cell anaemia: determining the significance of haematological values and nutrition","volume":"181","author":"Rankine-Mullings","year":"2018","journal-title":"Br J Haematol"},{"issue":"2","key":"2025062711213308400_bib24","doi-asserted-by":"crossref","first-page":"e55653","DOI":"10.1371\/journal.pone.0055653","article-title":"The association between cognition and academic performance in Ugandan children surviving malaria with neurological involvement","volume":"8","author":"Bangirana","year":"2013","journal-title":"PLoS One"},{"issue":"11","key":"2025062711213308400_bib25","doi-asserted-by":"crossref","first-page":"e7898","DOI":"10.1371\/journal.pone.0007898","article-title":"Socioeconomic predictors of cognition in Ugandan children: implications for community interventions","volume":"4","author":"Bangirana","year":"2009","journal-title":"PLoS One"},{"issue":"suppl 7","key":"2025062711213308400_bib26","first-page":"7310","article-title":"Statistical approaches to assess the effects of disease on neurocognitive function over time","author":"Bergemann","year":"2012","journal-title":"J Biom Biostat"},{"issue":"1","key":"2025062711213308400_bib27","doi-asserted-by":"crossref","first-page":"e92","DOI":"10.1542\/peds.2007-3709","article-title":"Cerebral malaria in children is associated with long-term cognitive impairment","volume":"122","author":"John","year":"2008","journal-title":"Pediatrics"},{"key":"2025062711213308400_bib28","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0079-6123(09)17808-1","article-title":"Neuropsychological assessment of African children: evidence for a universal brain\/behavior omnibus within a coconstructivist paradigm","volume":"178","author":"Boivin","year":"2009","journal-title":"Prog Brain Res"},{"issue":"3","key":"2025062711213308400_bib29","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1055\/s-0038-1637020","article-title":"Validity of neuropsychological testing in young African children affected by HIV","volume":"13","author":"Chernoff","year":"2018","journal-title":"J Pediatr Infect Dis"},{"issue":"3","key":"2025062711213308400_bib30","first-page":"186","article-title":"A preliminary examination of the construct validity of the KABC-II in Ugandan children with a history of cerebral malaria","volume":"9","author":"Bangirana","year":"2009","journal-title":"Afr Health Sci"},{"key":"2025062711213308400_bib31","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1017\/gmh.2015.2","article-title":"Executive function and attention-deficit\/hyperactivity disorder in Ugandan children with perinatal HIV exposure","volume":"2","author":"Burkey","year":"2015","journal-title":"Glob Ment Health (Camb)"},{"issue":"7","key":"2025062711213308400_bib32","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1017\/S1355617724000286","article-title":"Neuropsychological application of the International Test Commission guidelines for translation and adapting of tests","volume":"30","author":"Nguyen","year":"2024","journal-title":"J Int Neuropsychol Soc"},{"issue":"7","key":"2025062711213308400_bib33","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/cid\/cir1037","article-title":"Neurocognitive and motor deficits in HIV-infected Ugandan children with high CD4 cell counts","volume":"54","author":"Ruel","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"1","key":"2025062711213308400_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/QAI.0000000000001305","article-title":"Impact of HIV and atiretroviral therapy on neurocognitive outcomes among school-aged children","volume":"75","author":"Brahmbhatt","year":"2017","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"2025062711213308400_bib35","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s12887-021-02676-2","article-title":"Neurocognitive function among HIV-infected children on protease inhibitor -based versus non-protease inhibitor based antiretroviral therapy in Uganda: a pilot study","volume":"21","author":"Nalwanga","year":"2021","journal-title":"BMC Pediatr"},{"issue":"2","key":"2025062711213308400_bib36","doi-asserted-by":"crossref","first-page":"e0191001","DOI":"10.1371\/journal.pone.0191001","article-title":"Exclusive breastfeeding promotion and neuropsychological outcomes in 5-8 year old children from Uganda and Burkina Faso: results from the PROMISE EBF cluster randomized trial","volume":"13","author":"Tumwine","year":"2018","journal-title":"PLoS One"},{"issue":"7","key":"2025062711213308400_bib37","doi-asserted-by":"crossref","first-page":"e20658","DOI":"10.2196\/20658","article-title":"Executive function after prenatal alcohol exposure in children in a South African population: cross-sectional study","volume":"5","author":"Louw","year":"2021","journal-title":"JMIR Form Res"},{"key":"2025062711213308400_bib38","unstructured":"Miller\n              DC\n            \n          . How to report and interpret the NEPSY-II scores within a school neuropsychological framework. Accessed 10 December 2024. https:\/\/www.txasp.org\/assets\/conference-materials\/2015\/nepsy2interpretguide3.pdf."},{"issue":"4","key":"2025062711213308400_bib39","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1007\/s11065-022-09538-3","article-title":"A systematic review of the validity and reliability of assessment tools for executive function and adaptive function following brain pathology among children and adolescents in low- and middle-income countries","volume":"32","author":"Kusi-Mensah","year":"2022","journal-title":"Neuropsychol Rev"},{"issue":"8","key":"2025062711213308400_bib40","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1080\/13854046.2010.526785","article-title":"Official position of the American Academy of Clinical Neuropsychology on serial neuropsychological assessments: the utility and challenges of repeat test administrations in clinical and forensic contexts","volume":"24","author":"Heilbronner","year":"2010","journal-title":"Clin Neuropsychol"},{"issue":"1","key":"2025062711213308400_bib41","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/08880018.2020.1810183","article-title":"Primary prevention of stroke in children with sickle cell anemia in sub-Saharan Africa: rationale and design of phase III randomized clinical trial","volume":"38","author":"Abdullahi","year":"2021","journal-title":"Pediatr Hematol Oncol"},{"issue":"1","key":"2025062711213308400_bib42","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1056\/NEJM199807023390102","article-title":"Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography","volume":"339","author":"Adams","year":"1998","journal-title":"N Engl J Med"},{"issue":"6","key":"2025062711213308400_bib43","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1182\/blood-2013-12-545186","article-title":"Magnetic resonance imaging\/angiography and transcranial Doppler velocities in sickle cell anemia: results from the SWiTCH trial","volume":"124","author":"Helton","year":"2014","journal-title":"Blood"},{"issue":"1","key":"2025062711213308400_bib44","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1186\/s13023-024-03454-w","article-title":"Neurocognitive functioning in adults with neurofibromatosis type 1- a nationwide population-based study","volume":"19","author":"Doser","year":"2024","journal-title":"Orphanet J Rare Dis"},{"issue":"14","key":"2025062711213308400_bib45","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1182\/blood.2023021575","article-title":"Hydroxyurea reduces infections in children with sickle cell anemia in Uganda","volume":"143","author":"Namazzi","year":"2024","journal-title":"Blood"},{"issue":"3","key":"2025062711213308400_bib46","first-page":"277","article-title":"Decline in processing speed tells only half the story: developmental delay in children living with sickle cell disease","volume":"11","author":"Walker","year":"2024","journal-title":"Children (Basel)"},{"issue":"7","key":"2025062711213308400_bib47","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1080\/13854046.2012.722685","article-title":"Practice effects: a unique cognitive variable","volume":"26","author":"Duff","year":"2012","journal-title":"Clin Neuropsychol"},{"issue":"1","key":"2025062711213308400_bib48","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/arclin\/acac066","article-title":"Test-retest reliability of a computerized neurocognitive battery in school-age children with HIV in Botswana","volume":"38","author":"Tsima","year":"2023","journal-title":"Arch Clin Neuropsychol"},{"issue":"2","key":"2025062711213308400_bib49","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1037\/0021-9010.92.2.373","article-title":"Retesting in selection: a meta-analysis of coaching and practice effects for tests of cognitive ability","volume":"92","author":"Hausknecht","year":"2007","journal-title":"J Appl Psychol"},{"key":"2025062711213308400_bib50","doi-asserted-by":"publisher","DOI":"10.1101\/2024.07.08.24309901","article-title":"Academic achievement in Ugandan children with sickle cell anaemia: a cross-sectional study","author":"Naggayi","year":"8  2024","journal-title":"medRxiv"},{"issue":"1","key":"2025062711213308400_bib51","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1016\/S2352-3026(21)00368-9","article-title":"Hydroxyurea for primary stroke prevention in children with sickle cell anaemia in Nigeria (SPRING): a double-blind, multicentre, randomised, phase 3 trial","volume":"9","author":"Abdullahi","year":"2022","journal-title":"Lancet Haematol"},{"key":"2025062711213308400_bib52","doi-asserted-by":"crossref","first-page":"786065","DOI":"10.3389\/fneur.2021.786065","article-title":"Academic performance of children with sickle cell disease in the United States: a meta-analysis","volume":"12","author":"Heitzer","year":"2021","journal-title":"Front Neurol"},{"issue":"2","key":"2025062711213308400_bib53","doi-asserted-by":"crossref","first-page":"e406","DOI":"10.1542\/peds.2012-0283","article-title":"Developmental function in toddlers with sickle cell anemia","volume":"131","author":"Armstrong","year":"2013","journal-title":"Pediatrics"},{"issue":"18","key":"2025062711213308400_bib54","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1001\/jama.2010.562","article-title":"Neuropsychological dysfunction and neuroimaging abnormalities in neurologically intact adults with sickle cell anemia","volume":"303","author":"Vichinsky","year":"2010","journal-title":"JAMA"},{"issue":"8","key":"2025062711213308400_bib55","doi-asserted-by":"crossref","first-page":"e0289642","DOI":"10.1371\/journal.pone.0289642","article-title":"Cognition and education benefits of increased hemoglobin and blood oxygenation in children with sickle cell disease","volume":"18","author":"MacEwan","year":"2023","journal-title":"PLoS One"},{"issue":"10","key":"2025062711213308400_bib56","doi-asserted-by":"crossref","first-page":"e27899","DOI":"10.1002\/pbc.27899","article-title":"Higher executive abilities following a blood transfusion in children and young adults with sickle cell disease","volume":"66","author":"Hood","year":"2019","journal-title":"Pediatr Blood Cancer"},{"issue":"21","key":"2025062711213308400_bib57","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1182\/blood.2023022011","article-title":"The influence of voxelotor on cerebral blood flow and oxygen extraction in pediatric sickle cell disease","volume":"143","author":"Brothers","year":"2024","journal-title":"Blood"},{"issue":"10","key":"2025062711213308400_bib58","doi-asserted-by":"crossref","first-page":"e209429","DOI":"10.1212\/WNL.0000000000209429","article-title":"Reversibility of cognitive deficits and functional connectivity with transfusion in children with sickle cell disease","volume":"102","author":"Power","year":"2024","journal-title":"Neurology"},{"issue":"2","key":"2025062711213308400_bib59","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/bjh.14235","article-title":"Hydroxycarbamide treatment and brain MRI\/MRA findings in children with sickle cell anaemia","volume":"175","author":"Nottage","year":"2016","journal-title":"Br J Haematol"},{"issue":"6","key":"2025062711213308400_bib60","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1080\/09297049.2018.1526272","article-title":"Associations of transcranial doppler velocity, age, and gender with cognitive function in children with sickle cell anemia in Nigeria","volume":"25","author":"Prussien","year":"2019","journal-title":"Child Neuropsychol"},{"key":"2025062711213308400_bib61","doi-asserted-by":"crossref","first-page":"390","DOI":"10.3389\/fpsyg.2014.00390","article-title":"Executive control training from middle childhood to adolescence","volume":"5","author":"Karbach","year":"2014","journal-title":"Front Psychol"},{"issue":"3","key":"2025062711213308400_bib62","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3102\/0034654314555996","article-title":"Are child cognitive characteristics strong predictors of responses to intervention? A meta-analysis","volume":"85","author":"Stuebing","year":"2015","journal-title":"Rev Educ Res"},{"issue":"1","key":"2025062711213308400_bib63","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cpr.2013.11.002","article-title":"Cognitive, language, social and behavioural outcomes in adults with autism spectrum disorders: a systematic review of longitudinal follow-up studies in adulthood","volume":"34","author":"Magiati","year":"2014","journal-title":"Clin Psychol Rev"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/12\/3116\/2381735\/blooda_adv-2024-015073-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/12\/3116\/2381735\/blooda_adv-2024-015073-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T11:21:47Z","timestamp":1751023307000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/9\/12\/3116\/536040\/Neurocognitive-gains-among-Ugandan-children-with"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,24]]},"references-count":63,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,6,24]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2024015073","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,6,24]]},"published":{"date-parts":[[2025,6,24]]}}}